Agonist or levodopa for Parkinson disease?
Final follow-up data from the Parkinson's Disease Research Group of the United Kingdom (PDRG-UK) trial shows no evidence of a long-term benefit or clinically relevant disease-modifying effect with initial dopamine agonist treatment....
Want to read complete article? Please Sign in or Register.